EGFR and glioblastoma: For instance, several studies showed the successful generation of anti-CD133, anti-EPCAM, or even anti-EGFR CAR T cells targeting CSCs from different parental tumors including glioblastoma or non-small-cell lung cancer [81,82,83] (see [80] for detailed review).